Strides Pharma Science informs about acquisition

15 Mar 2025 Evaluate

Strides Pharma Science has informed that Strides Pharma Global (‘SPG’), a step-down wholly-owned subsidiary of the Company in Singapore, proposes to create a platform that shall foster introductions, collaborations, procurement and business engagement between pharmaceutical manufacturers and suppliers of India, China, and other Southeast-Asian countries. In this regard, it is proposed to acquire 100% stake in Amexel, Singapore, which will be utilized as the entity for the above business platform. Disclosure under Regulation 30 of SEBI Listing Regulations for the said acquisition is enclosed.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

658.05 -20.95 (-3.09%)
27-Mar-2025 12:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1725.25
Dr. Reddys Lab 1151.55
Cipla 1470.10
Lupin 2022.15
Zydus Lifesciences 888.90
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...